Genmab reported DKK2.12B in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
AstraZeneca AZN:LN 12011M 2145M
Bayer BAYN:GR € 11118M 1337M
Bluebird Bio BLUE:US $ 1.61M 21.07M
Fresenius Medical Care FME:GR € 4647M 206M
Genmab GEN:DC DK 2119M 500M
GRIFOLS GRF:SM € 1351.9M 167.16M
Hikma Pharmaceutical HIK:LN 1.34B 121M
Immunogen IMGN:US $ 38.08M 10.09M
Lonza Group LONN:SW 2.87B 325M
Novartis NOVN:VX SF 13522M 155M
William Demant Holding WDH:DC 9.38B 364M